Discover your next big idea in food packaging & processing this month
Experience a breakthrough in food packaging & processing—explore solutions from 2,300 suppliers spanning all industries at PACK EXPO Las Vegas.

FDA Issues Final Guidance for Use of ISO 10993-1 for Medical Devices

The document provides further clarification and updated information on the use of International Standard ISO 10993–1, “Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process.”

Fda Building

The FDA has announced the availability of a final guidance entitled “Use of International Standard ISO 10993–1, ‘Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process’.” The guidance incorporates updates to the FDA’s current thinking regarding the type of biocompatibility information that should be provided in a premarket submission for certain devices made from common polymers and fabrics that are in contact with intact skin. The Center for Devices and Radiological Health (CDRH) will host a webinar on Oct. 12, 2023 for industry members and others interested in learning more about the guidance.

The purpose of the guidance is to provide further clarification and updated information on the use of International Standard ISO 10993–1, to support premarket approval applications (PMAs), humanitarian device exemptions (HDEs), investigational device exemption (IDE) applications, premarket notifications (510(k)s), and De Novo requests for medical devices that come into direct contact or indirect contact with the human body in order to determine the potential for an unacceptable adverse biological response resulting from contact of the component materials of the device with the body.

The guidance adds, within a new attachment (Attachment G), recommendations which reflect the agency’s current thinking about the type of biocompatibility information that should be provided in a medical device premarket submission for certain devices in contact with intact skin. It incorporates several considerations, including the use of risk-based approaches to determine if biocompatibility testing is needed, chemical assessment recommendations, recommendations for biocompatibility test article preparation for devices with submicron or nanotechnology components and for devices made from in situ polymerizing and/or absorbable materials, and biocompatibility recommendations when certain materials only contact intact skin.

To submit an electronic comment, including any attachments, go to https://www.regulations.gov.


Fill out the form below to request more information about FDA Issues Final Guidance for Use of ISO 10993-1 for Medical Devices
Construction strategies for volatile F&B markets
See how leading manufacturers are fast-tracking projects despite economic uncertainty. Get proven tactics for overcoming tariffs, labor shortages, and rising costs.
Read More
Construction strategies for volatile F&B markets
Liquid Foods Innovations Report
Welcome to the inaugural Packaging World/ProFood World Innovations Report on liquid food packaging, drawn from nearly 300 PACK EXPO International booth visits (Chicago, Nov. 3–6, 2024). Our editors highlight the most groundbreaking equipment and materials—supported by video demos—that promise to transform how liquid foods are processed, packaged, and delivered.
Learn More
Liquid Foods Innovations Report